Tag: diffuse large b cell lymphoma

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Preexisting heart failure associated with lower use of anthracyclines and chemotherapy

byZoya Gomesand1 others

April 9, 2023

1. In this longitudinal cohort study of 30 728 patients with diffuse large-B-cell lymphoma, preexisting heart failure at lymphoma diagnosis ...

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

byNeel Mistryand1 others

June 29, 2022

1. Median event-free survival in the liso-cel group was significantly greater than in the standard-of-care group (10.1 months vs. 2.3 ...

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

byKathleen Lau

November 12, 2021

#VisualAbstract Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

byKathleen Lau

November 11, 2021

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

byKathleen Lau

January 7, 2021

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: diffuse large b cell lymphoma

Preexisting heart failure associated with lower use of anthracyclines and chemotherapy

Lisocabtagene maraleucel improves survival for relapsed or refractory large B-cell lymphoma

#VisualAbstract Lenalidomide in combination with R-CHOP is effective in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma

#VisualAbstract Acalabrutinib monotherapy has acceptable tolerability and limited response in patients with Richter transformation

#VisualAbstract Progression-Free Survival (PFS) was significantly longer with intensive chemotherapy in patients with advanced stage double or triple hit lymphoma (DHL, THL)

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports